Option chain shows key data for Polyrizon's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Polyrizon.

Polyrizon (NASDAQ:PLRZ) Stock, Option Chain

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.

Wall Street

Equities

Market Summary

News

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

Trading Ideas

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

HSIC

PLRZ

RNAZ

U.S. stock futures fell on Monday after a nine-day winning streak on the S&amp;P 500 index. Futures of benchmark indices were lower in premarket.

US Stocks Likely To Open Lower After S&amp;P 500&#39;s 9-Day Streak: &#39;Any De-Escalation In Trade Tensions Should Be Positive,&#39; Says Expert

Display,Of,Stock,Market,Quotes

Movers

AGMH

CLIK

ESOA

FRGT

JCSE

NCNA

NITO

QNCX

SBET

Morgan Stanley Capital-Protected Notes Based on Value of S&P 500 Index

TZUP

UMAC

ZBAI

Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Nasdaq,Inscription,Next,To,Us,Dollars.,The,Nasdaq,Is,An

Earnings

Eurozone

Commodities

Intraday Update

AAPL

ADPT

CABO

DPRO

PAPL

Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results

Polyrizon Ltd

Press Releases

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Health Care

General

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Polyrizon Ltd. Announces $17.0 Million Private Placement

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

CMND

CSE:CMND

Aligos Therapeutics

Allakos

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Annovis Bio

BioAtla

bluebird bio

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Dyadic International, Inc. - Common Stock

Dyadic International

FibroBiologics

FibroGen

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

MiNK Therapeutics

Kezar Life Sciences

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

OSR Holdings

Polyrizon

Pluri

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Rein Therapeutics

RenovoRx

Spero Therapeutics

Surrozen

Xilio Therapeutics

Comments

Polyrizon

Polyrizon (PLRZ) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell